News | March 14, 2024
Cureskin secures US$ 20 million in Series B funding
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Cureskin aims to disrupt the large and growing skin and hair care industry in India
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
It is the first autotaxin inhibitor to be investigated in cancer patients
Acquisition of exclusive commercialization rights for European markets
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Launch of Indian public health standards for Ayush healthcare facilities
Subscribe To Our Newsletter & Stay Updated
